Search Results - "Rousselet, M. C."

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH by Boursier, J., Anty, R., Vonghia, L., Moal, V., Vanwolleghem, T., Canivet, C. M., Michalak, S., Bonnafous, S., Michielsen, P., Oberti, F., Iannelli, A., Van Gaal, L., Patouraux, S., Blanchet, O., Verrijken, A., Gual, P., Rousselet, M.‐C., Driessen, A., Hunault, G., Bertrais, S., Tran, A., Calès, P., Francque, S.

“…Summary Background The composite histological endpoint comprising nonalcoholic steatohepatitis (NASH) and NAFLD activity score ≥4 and advanced fibrosis (F ≥ 2)…”
Get full text

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C by Boursier, J., Brochard, C., Bertrais, S., Michalak, S., Gallois, Y., Fouchard‐Hubert, I., Oberti, F., Rousselet, M.‐C., Calès, P.

“…Summary Background Recent longitudinal studies have emphasised the prognostic value of noninvasive tests of liver fibrosis and cross‐sectional studies have…”
Get full text

Noninvasive diagnosis of hepatic fibrosis or cirrhosis by Oberti, F, Valsesia, E, Pilette, C, Rousselet, MC, Bedossa, P, Aube, C, Gallois, Y, Rifflet, H, Maiga, MY, Penneau-Fontbonne, D, Cales, P

“…BACKGROUND & AIMS: The evaluation of the degree of hepatic fibrosis is especially important in patients with chronic liver disease. The aim of this study was…”
Get full text

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis by Aubé, Christophe, Oberti, Frédéric, Korali, Nouri, Namour, Marc-Antoine, Loisel, Didier, Tanguy, Jean-Yves, Valsesia, Emmanuelle, Pilette, Christophe, Rousselet, Marie Christine, Bedossa, Pierre, Rifflet, Hervé, Maïga, Moussa Y, Penneau-Fontbonne, Dominique, Caron, Christine, Calès, Paul

“…Background/Aims: Evaluation of the degree of hepatic fibrosis is especially important in patients with chronic liver disease. Our aim was to study the…”
Get full text

Non-invasive diagnosis of esophageal varices in chronic liver diseases by Pilette, Christophe, Oberti, Frédéric, Aubé, Christophe, Rousselet, Marie Christine, Bedossa, Pierre, Gallois, Yves, Rifflet, Hervé, Calès, Paul

“…Background/Aims: The primary prevention of bleeding from esophageal varices is a major therapeutic issue requiring early screening of esophageal varices. Our…”
Get full text

Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies by Foussard, C., Colombat, P., Maisonneuve, H., Berthou, C., Gressin, R., Rousselet, M.-C., Rachieru, P., Pignon, B., Mahé, B., Ghandour, C., Desablens, B., Casassus, P., Lamy, T., Delwail, V., Deconinck, E.

“…Background: This randomized study compared the efficacy and safety of fludarabine–mitoxantrone (FM) with mini-CHVP (cyclophosphamide, doxorubicin, vindesine,…”
Get full text

Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: A review by Fonseca, R., Yamakawa, M., Nakamura, S., van Heerde, P., Miettinen, M., Shek, T.W. H., Jensen, O. Myhre, Rousselet, M. C., Tefferi, A.

“…Neoplasms of reticular dendritic origin are extremely rare and include the follicular dendritic cell sarcoma (FDCS) and the interdigitating reticulum (or…”
Get full text

Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients by Visée, S, Soltner, C, Rialland, X, Machet, M C, Loussouarn, D, Milinkevitch, S, Pasco-Papon, A, Mercier, P, Rousselet, M C

“…Aims : To examine the clinical and pathological characteristics of supratentorial primitive neuroectodermal tumours (PNETs) in a retrospective series of 18…”
Get full text

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease by Boursier, J, Vergniol, J, Lannes, A, Hiriart, J.-B, Oberti, F, Le Bail, B, Michalak, S, Chermak, F, Bertrais, S, Foucher, J, Fouchard-Hubert, I, Charbonnier, M, Rousselet, M.-C, Cales, P, de Ledinghen, V

Get full text

Sex-related C cell hyperplasia in the normal human thyroid : A quantitative autopsy study by GUYETANT, S, ROUSSELET, M.-C, DURIGON, M, CHAPPARD, D, FRANC, B, GUERIN, O, SAINT-ANDRE, J.-P

“…We report a prospective quantitative image analysis study of C cells in 57 normal autopsy thyroid glands, serially sectioned and wholly embedded in paraffin;…”
Get full text

Impact of partial nephrectomy in a hybrid operating room on the activity of kidney cancer surgery by Aubert, C, Rolley, C, Mauny, M, Heuveline, J, Silve, E, Humeau, M, Le Corre, V, Lebdai, S, Brassart, E, Culty, T, Baize, N, Rousselet, M C, Nedelcu, C, Aubé, C, Bouvier, A, Bigot, P

“…Partial nephrectomy (NP) after embolization of tumor vessels (NPESH) in a hybrid room combines embolization of tumor vessels and enucleation of the tumor under…”
Get more information

Interobserver agreement in the staging of rectal cancer using endoscopic ultrasonography by Burtin, P, Rabot, A F, Heresbach, D, Carpentier, S, Rousselet, M C, Le Berre, N, Boyer, J

“…In rectal tumors invasion of the rectal fat and perirectal lymph nodes are generally regarded as independent prognostic factors in most prospective series…”
Get more information

Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats by Fort, Joël, Oberti, Frédéric, Pilette, Christophe, Veal, Nary, Gallois, Yves, Douay, Olivier, Rousselet, Marie Christine, Rosenbaum, Jean, Calès, Paul

“…The aim of this study was to assess the effect of the early and chronic administration of octreotide in the prevention of hepatic fibrosis and portal…”
Get full text

Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study by Orvain, C., Luque Paz, D., Dobo, I., Cottin, L., Le Calvez, G., Chauveau, A., Mercier, M., Farhi, J., Boyer, F., Ianotto, J. C., Guibourg, B., Rousselet, M. C., Zandecki, M., Ifrah, N., Hunault-Berger, M., Ugo, V., Genevieve, F.

“…A high number of circulating CD34+ cells has been advocated to distinguish primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms…”
Get full text

Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma : A review by FONSECA, R, YAMAKAWA, M, NAKAMURA, S, VAN HEERDE, P, MIETTINEN, M, SHEK, T. W. H, JENSEN, O. M, ROUSSELET, M. C, TEFFERI, A

Get full text

P0989 : A combination of elastometry and blood markers improves the non-invasive staging of liver fibrosis in NAFLD by Boursier, J, Vergniol, J, Guillet, A, Hiriart, J.-B, Le Bail, B, Michalak, S, Bertrais, S, Chermak, F, Oberti, F, Foucher, J, Fouchard-Hubert, I, Charbonnier, M, Rousselet, M.-C, Cales, P, de Ledinghen, V

Get full text

15 FIRST INTENTION-TO-DIAGNOSE COMPARISON OF ARFI AND FIBROSCAN IN CHRONIC LIVER DISEASES by Bardou, D, Boursier, J, Cartier, V, Lebigot, J, Michalak, S, Oberti, F, Fouchard-Hubert, I, Rousselet, M.-C, Aube, C, Calès, P

Get full text

1141 IMPACT OF LIVER BIOPSY FRAGMENT LENGTH AND LOCATION ON AUTOMATED QUANTITATIVE MEASURES OF FIBROSIS AND STEATOSIS by Bertrais, S, Chaigneau, J, Joly, L, Michalak, S, Rousselet, M.-C, Calés, P

Get full text

Fibrinogen angers with a new deletion (γ GVYYQ 346‐350) causes hypofibrinogenemia with hepatic storage by DIB, N., QUELIN, F., TERNISIEN, C., HANSS, M., MICHALAK, S., DE MAZANCOURT, P., ROUSSELET, M. C., CALÈS, P.

“…Introduction: This study reports a family with chronically abnormal blood liver function tests (LFT) and congenital hypofibrinogenemia. The proposita had…”
Get full text

Post-treatment MRI aspects of photodynamic therapy for prostate cancer by Kulik, M., Nedelcu, C., Martin, F., Lebdai, S., Rousselet, M. C., Azzouzi, A. R., Aubé, C.

“…Objectives Photodynamic therapy is a new focal therapy for prostate cancer. Methods In this technique, a photosensitising agent is introduced intravenously,…”
Get full text